TREM1 and Neonatal sepsis: We further demonstrate that M3, an eCIRP-derived TREM-1 inhibitor, decreases systemic, pulmonary, and cardiac inflammation, improves cardiac dysfunction, and increases survival in a murine model of neonatal sepsis.